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Abstract
Introduction Little information is available on prognosis and
outcomes of very long stay intensive care unit (ICU) patients.
The purpose of this study was to identify long-term outcomes
after hospital discharge and readily available clinical predictors
of hospital mortality for patients requiring prolonged care in the
ICU.
Method Clinical data were collected from consecutive patients
requiring at least 30 days of ICU care admitted over 3 calendar
years (2001 to 2003) to a medical/surgical ICU in a university-
affiliated tertiary care centre.
Results A total of 182 patients met the inclusion criteria, with a
mean age of 63 years, median ICU stay of 48.5 days
(interquartile range 36–78 days) and ICU mortality of 32%. They
accounted for 8% of total admissions and 48% of total
occupied beds. Of these patients, 42% died in hospital, 44%
returned to their previous place of residence, and 14% were
transferred to long-term care institutions. By 6 months after
hospital discharge a further 8% of the patients had died, 40%
remained at their previous place of residence, and 10% were in
long-term care. Predictors of hospital mortality, identified using
multivariate logistic regression, included age (odds ratio [OR]
1.45 per additional decade, 95% confidence interval [CI] 1.10–
1.91), any immunosuppression (OR 5.2, 95% CI 1.7–15.5),
mechanical ventilation for longer than 90 days (OR 4.0, 95% CI
1.3–12.0), treatment with inotropes or vasopressors for more
than 3 days at or after day 30 in the ICU (OR 7.1, 95% CI 2.6–
19.3), and acute renal failure requiring dialysis at or after day 30
in the ICU (OR 6.3, 95% CI 2.0–19.7).
Conclusion Patients with very long stays in the ICU appear to
have a reasonable chance of survival, with most survivors in
our cohort residing at their previous place of residence 6
months after hospital discharge. Prolonged requirement for
life support therapies (ventilation, vasoactive agents, or acute
dialysis) and a limited number of pre-existing co-morbidities
(immunosuppression and, to a lesser extent, patient age) were
predictors of increased hospital mortality. These predictors
may assist in clinical decision making for this resource
intensive patient population, and their reproducibility in other
very long stay patient populations should be explored.
Introduction
Long-stay intensive care unit (ICU) patients, variably defined
as requiring longer than 5–14 days of intensive care, have
been shown to have high mortality rates and consume signifi-
cant resources [1-16]. Much less information is available on
very long stay ICU patients, defined as requiring at least 28–
30 days of ICU care [5,14,17-19]. The management of these
patients can be particularly challenging for the multidiscipli-
nary ICU team because of intense use of ICU resources that
are limited, the challenges presented by a protracted weaning
process, and uncertain long-term outcomes. Currently, prog-
nostication for the very long stay ICU patient is imprecise.
Most illness severity [20,21] or organ dysfunction [22,23]
scoring systems were designed for patients with shorter ICU
stays, and the predictive value of admission scoring systems
based on acute physiological derangements decreases signif-
icantly beyond 7 days [24]. Given the challenges posed by
this patient population and imprecise prognostication sys-
tems, the objectives of this study were as follows: to determine
hospital and 6 month outcomes of a mixed population of med-
APACHE = Acute Physiology and Chronic Health Evaluation; CI = confidence interval; ICU = intensive care unit; IQR = interquartile range; OR = 
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ical/surgical patients requiring at least 30 days of ICU care;
and to identify predictors associated with hospital mortality
using ICU data readily available to clinicians at the bedside.
Materials and methods
Data sources
The study was conducted in the closed 24 bed medical/surgi-
cal ICU at St. Michael's Hospital, a tertiary-care academic cen-
tre affiliated to the University of Toronto. Patients requiring
mechanical ventilation or intense physiological support or
monitoring were admitted to the ICU and cared for by a multi-
disciplinary health care team under the direction of an attend-
ing intensive care physician. All decisions regarding patient
care were made independent of data collection. The institution
has separate neurosurgical/trauma, cardiac surgery and coro-
nary care units that also accepted ventilated patients. Patients
in these other units were only included in the study if they
required transfer to the medical/surgical ICU for at least part
of their hospital stay. No long-term ventilator unit exists within
the institution, and so all ventilated patients remained in one of
the acute care ICUs until transfer to a facility that could accom-
modate such patients.
Data collection
Over a 3 year period (1 January 2001 to 31 December 2003),
all admissions to the medical/surgical ICU were identified and
all patients requiring at least 30 (consecutive or nonconsecu-
tive) days of ICU care during their hospital admission were
included in the study. Two study investigators (JF and GW)
retrospectively reviewed each patient chart independently;
disagreements were resolved by consensus. Baseline demo-
graphic data, including age, sex, body mass index, initial ICU
admission diagnosis and severity of illness score (Acute Phys-
iology and Chronic Health Evaluation [APACHE] II score [20]),
were recorded at the time of initial ICU admission.
In addition, the presence of any baseline or ICU-acquired co-
morbidities were recorded and grouped by system. The co-
morbidities were selected a priori after informal discussion
with intensive care physicians at the study hospital, who were
asked to identify co-morbidities that contribute to increased
length of stay or higher mortality in the very long stay patient
population. These co-morbidities (with definitions) included
the following: obesity (body mass index = 30 kg/m2), diabetes
(by history, or if admitted with diabetic ketoacidosis or hypo-
volaemic hyperosmotic nonketotic coma, or if discharged on
glucose lowering medications), chronic obstructive or restric-
tive lung disease (by history or radiographic imaging or pulmo-
nary function testing), congestive heart failure (significant
systolic or diastolic dysfunction by echocardiography), disa-
bling neurological conditions (impaired cognition or muscle
strength sufficient to impede ventilator weaning, as deter-
mined by review of the clinical notes), end-stage renal disease
(requiring dialysis before admission), chronic liver disease
(based on signs and symptoms of portal hypertension), any
malignancy (excluding previously resected nonmelanoma skin
cancers) and immunosuppression (ongoing requirement of
any dose of steroids or other immunosuppressant medica-
tions, or HIV infection).
For each patient, we also recorded details of the ICU course
(total number of ICU days, and days requiring invasive or non-
invasive ventilatory support, renal replacement therapy for
acute renal failure, and haemodynamic support with inotropes
or vasopressors at any dose) and outcomes (ICU, hospital and
6 month mortality, and place of residence at hospital dis-
charge and 6 months after discharge). Data regarding total
length of ICU stay and days requiring life support therapies
were incomplete for nine (5%) patients as a result of transfers
between referring hospitals. However, demographics, co-mor-
bidities, survival and place of residence up to 6 months after
hospital discharge were available for all patients. For patients
requiring more than one admission to the ICU during their hos-
pital stay, their ICU course was recorded cumulatively, includ-
ing data from all ICU admissions during the hospital stay.
The study protocol was approved by the hospital's research
ethics board, which waived the need for informed consent.
Statistical analyses
Agreement for recorded data between two investigators was
evaluated using the kappa statistic for categorical variables,
and Pearson correlation and paired t  test for APACHE II
scores. Baseline demographics, co-morbidities, and durations
of ICU stay and life support therapies for hospital survivors and
nonsurvivors were analyzed using Student's t  or Wilcoxon
tests for normally and non-normally distributed continuous var-
iables, respectively. χ2 or Fisher's exact test were used for cat-
egorical variables. Continuous variables are summarized as
mean ± standard deviation or median (interquartile range
[IQR]) for normally and non-normally distributed variables,
respectively.
For multivariate analysis, the skewed continuous variables
(ICU readmissions and days requiring ICU care, mechanical
ventilation, inotropes or vasopressors, or dialysis) were con-
verted to binary variables that would be easily available to bed-
side clinicians for patients requiring at least 30 days of ICU
care; the approach was as follows. Cutoff points for number of
ICU readmissions, ICU length of stay and duration of ventila-
tion (both in multiples of 30 days) were chosen as the values
after which there was the greatest change in hospital survival.
We defined a priori haemodynamic support as the require-
ment of inotropic or vasopressor agents on at least 3 (consec-
utive or nonconsecutive) days from day 30 in ICU onward (to
exclude patients requiring only a very brief period of haemody-
namic support after day 30). Similarly, acute renal failure was
defined as the requirement for dialysis in the ICU after day 30.Available online http://ccforum.com/content/10/2/R59
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All variables with a P value below 0.20 by univariate logistic
regression analysis were entered into a multivariate logistic
regression model using backward selection. Variables with a
P value below 0.10 were retained in the multivariate model,
and these retained variables were assessed for collinearity or
the presence of significant second-order interactions. Discrim-
ination of the model was assessed by the area under the
receiver operating characteristic curve. Calibration was
assessed using the Hosmer and Lemeshow X2 statistic. We
report odds ratio (OR) and 95% confidence interval (CI), and
interpreted two-sided P < 0.05 as being statistically signifi-
cant. All statistical calculations were carried out using SAS
version 8.2 (SAS Institute Inc., Cary, NC, USA).
Results
Over the 3-year study period there were a total of 3,172
admissions; of these, 2,716 patients survived (ICU mortality
rate 14%). There were 171 patients who had at least one stay
Table 1
Patient characteristics
Characteristic Survivors (n = 106) Nonsurvivors (n = 76) P
Comorbidites
Age (years [mean ± SD]) 61 ± 17 65 ± 15 0.11
Female sex 40 (38%) 28 (37%) 0.90
Obese (i.e. BMI > 30 kg/m2) 27 (26%) 17 (22%) 0.58
Diabetes 16 (15%) 23 (30%) 0.014
Congestive heart failure 16 (15%) 19 (25%) 0.09
Disabling neurological disease 33 (31%) 22 (29%) 0.75
Lung disease 32 (30%) 25 (33%) 0.70
ESRD 4 (4%) 5 (7%) 0.39
Liver disease 2 (2%) 3 (4%) 0.65a
Immunocompromised 10 (9%) 16 (21%) 0.03
Cancer 15 (14%) 12 (16%) 0.76
ICU admission
Place of residence before hospital admission
Home 99 (93%) 70 (92%) 0.48a
Nursing homeb 4 (4%) 5 (7%)
Tracheostomyc 3 (3%) 0 (0%)
Ventilatedd 0 (0%) 1 (1%)
Admission APACHE II score (mean ± SD) 23 ± 8 26 ± 9 0.005
Medical admission 58 (55%) 46 (61%) 0.43
Nonelective admission 88 (83%) 63 (83%) 0.98
Admission diagnostic group 0.21a
Respiratory 35 (33%) 31 (41%)
Cardiovascular 24 (23%) 21 (28%)
Gastrointestinal 29 (27%) 9 (12%)
Neurological 11 (10%) 4 (5%)
Genitourinary 2 (2%) 6 (8%)
Other 5 (5%) 5 (7%)
Values are expressed as n (%) except where noted otherwise. aP value obtained using Fisher's exact test. b'Nursing home' refers to a patient from 
a long-term care institution without a permanent tracheostomy. c'Tracheostomy' refers to a nonventilated patient with a permanent tracheostomy 
from a long-term care institution. d'Ventilated' refers to a chronically ventilated patient from a long-term care institution. APACHE, Acute Physiology 
and Chronic Health Evaluation; BMI, body mass index; COPD, chronic obstructive pulmonary disease; ESRD, end-stage renal disease; ICU, 
intensive care unit; SD, standard deviation.Critical Care    Vol 10 No 2    Friedrich et al.
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of 30 or more consecutive days in ICU, and 11 patients who
had more than one admission adding up to 30 or more total
days in ICU. These 182 patients had a total of 266 ICU admis-
sions during their hospital stay (median total ICU stay 48.5
days, IQR 36–78 days; and median total hospital stay 85
days, IQR 56–133 days). ICU mortality in these patients was
32%. This cohort represented 8% of total admissions but
occupied 48% of the total bed days.
Patient demographics, co-morbidites and characteristics at
ICU admission of the hospital survivors and nonsurvivors are
shown in Table 1. There was good agreement between raters
for each of the co-morbidity characteristics (kappa ranged
from 0.75 to 1.00) and admission APACHE II scores (correla-
tion coefficient r = 0.87), with an average difference in scores
of 2.1 ± 4.3 (P = 0.002). Most (>90%) of the very long stay
patients lived independently before their ICU admission. The
ICU admissions were emergent in the majority of cases with a
mean APACHE II score of 24 ± 8. The median number of co-
morbidities was 2 (IQR 1–2).
These very long stay patients had the following outcomes:
42% died in hospital, 44% were discharged either to their pre-
vious place of residence or rehabilitation (with the expectation
that they would return to their previous place of residence),
and the remaining 14% were discharged to long-term care
institutions with the expectation that these patients would
require care in these long-term care institutions indefinitely. Of
the 14% discharged to long-term care institutions, 6% were
discharged with no permanent tracheostomy, 6% were dis-
charged with a permanent tracheostomy but not chronically
ventilated, and 2% were chronically ventilated. Fourteen
patients (8% of the entire cohort) died during the 6 months fol-
lowing hospital discharge and one patient successfully
returned home from a long-term care institution. Thus, at 6
months, 50% of patients had died, 40% were living in their
previous place of residence, and 10% were living in long-term
care institutions.
Details regarding patients' ICU course are shown in Table 2.
All but one patient required ventilation; patients had a median
of 7 (IQR 3-13.5) nonventilated days in ICU. Seventy per cent
of patients required inotrope or vasopressor support at some
point while they were in the ICU, and 16% required dialysis for
acute renal failure. Most patients who required inotrope or
vasopressor support early during their ICU admission no
Table 2
Intensive care unit course
Characteristic Survivors (n = 106) Nonsurvivors (n = 76) P
Number of ICU readmissions
0 76 (72%) 47 (63%) 0.07a
1 24 (23%) 17 (23%)
2 2 (2%) 6 (8%)
>2 3 (3%) 4 (6%)
Total duration of ICU stay (days)
Median 48 54 0.14b
Interquartile range 35–70 36–96
Requiring ventilation 106 (100%) 75 (99%) 0.42c
Total duration of ventilation (days)
Median 39 46 0.002d
Interquartile range 29–53 34–86
Requiring inotropes/vasopressors at any time in the ICU 65 (61%) 64 (84%) 0.0008
Requiring inotropes/vasopressors for at least 3 days at or after day 30 8/103 (8%) 26/70 (37%) <0.000
1
ARF requiring dialysis at any time in ICU (excluding ESRD) 6 (6%) 23/75 (30%) <0.000
1
ARF requiring dialysis at or after day 30 (excluding ESRD) 5 (5%) 22/75 (29%) <0.000
1
Values are expressed as n (%) except where noted otherwise. aP = 0.02 using χ2 test comparing patients with 0–1 readmissions versus patients 
with >1 readmissions (also see Figure 3). bP value obtained using Wilcoxon Rank Sum test; P = 0.02 using χ2 test comparing patients requiring 
<90 days of ICU care versus patient requiring >90 days of ICU care (also see Figure 1). cP value obtained using Fisher's exact test. dP value 
obtained using Wilcoxon rank sum test; P = 0.007 using χ2 test comparing patients requiring <90 days of ventilation versus patient requiring >90 
days of ventilation (also see Figure 2). ARF, acute renal failure; ESRD, end-stage renal disease; ICU, intensive care unit.Available online http://ccforum.com/content/10/2/R59
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longer required such support from day 30 onward. In contrast,
most patients dialyzed for acute renal failure still required this
therapy at or after day 30. However, all survivors to 6 months
after hospital discharge who had required dialysis for acute
renal failure recovered renal function.
Compared with those who survived to hospital discharge, non-
survivors were older, and more of these patients had diabetes,
congestive heart failure, or were immunocompromised (Table
1). The nonsurvivors also had higher APACHE II scores at ICU
admission, more readmissions, more ICU and ventilator days,
and more of these patients required inotrope or vasopressor
support or dialysis (Tables 1 and 2). The most significant
change in hospital survival occurred after 90 days in the ICU
(Figure 1; P = 0.02) or 90 days of ventilation (Figure 2; P =
0.007). Hospital survival was not affected by one ICU readmis-
sion, but multiple ICU readmissions were associated with
increasing risk for mortality (Figure 3; P = 0.02).
Based on these results, the following variables were entered
into the multivariate logistic regression model: the continuous
variables of age and APACHE II score; and the binary varia-
bles of diabetes, congestive heart failure, immunosuppression,
more than one readmission to ICU, ICU length of stay greater
than 90 days, duration of ventilation greater than 90 days,
requirement for inotropic support on at least 3 days from day
30 in the ICU, and acute renal failure requiring dialysis in ICU
from day 30. The results of the multivariate logistic regression
model identifying predictors of hospital survival are shown in
Table 3. Increasing age (OR 1.45 per incremental decade,
95% CI 1.10–1.91), immunosuppression (OR 5.2, 95% CI
1.7–15.5), more than 90 ventilator days (OR 4.0, 95% CI 1.3–
12.0), acute renal failure requiring dialysis at or after day 30
(OR 6.3, 95% CI 2.0–19.7), and inotropic support on at least
3 days at or after day 30 in ICU (OR 7.1, 95% CI 2.6–19.3)
were all independent predictors of higher hospital mortality.
The area under the receiver operating characteristic curve for
this model was 0.80. There was no evidence of lack of calibra-
tion (P = 0.29 for the final model), and there was no significant
collinearity or second-order interactions among these varia-
bles. Hospital survival decreased markedly as the number of
non-age-related clinical predictors of hospital mortality
increased, from 75 out of 95 (79%) with no predictors to 26
out of 55 (47%) with one predictor, two out of 16 (13%) with
two predictors, and none out of six (0%) with three predictors
(Figure 4).
Discussion
The major findings of this study are as follows. Patients who
required at least 30 days of ICU care during their hospital stay
comprised only a small proportion of total ICU admissions but
they occupied a large proportion of total bed days. More than
half of these very long stay patients survived to hospital dis-
charge, with the vast majority returning to their previous place
Figure 2
Hospital survival by number of ventilator days Hospital survival by number of ventilator days. se, standard error.
Figure 1
Hospital survival by number of ICU days Hospital survival by number of ICU days. ICU, intensive care unit; se, standard error.Critical Care    Vol 10 No 2    Friedrich et al.
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of residence by 6 months after hospital discharge. Independ-
ent predictors of hospital mortality in these patients were age,
immunosuppression, greater than 90 ventilator days, acute
renal failure requiring dialysis at or after day 30 in the ICU, and
inotrope support on at least 3 days at or after day 30 in the
ICU.
The finding that very long stay patients consumed a high pro-
portion of total patient days is consistent with those of other
studies. Studies conducted in medical/surgical, cardiovascu-
lar and pediatric ICU patients using shorter (7–14 days) defi-
nitions of long stay found that these patients accounted for
only 4–11% of admissions while consuming 28–53% of avail-
able bed days [5,8,9,15,25-28]. Moreover, our observed hos-
pital mortality (42%) is comparable with rates reported in other
studies (40–53%) enrolling patients with at least 28–30 days
in ICU [5,17-19]. Longer term (6 month to 1 year) mortality
rates of 55–57% in recent studies enrolling patients after 14
days in ICU or 14 days of ventilation [7,13,16] were similar to
our finding of 50% mortality at 6 months after hospital dis-
charge. Six month outcomes from our study may be more sim-
ilar to longer term outcomes in hospital systems commonly
used in the USA, where patients are discharged from an acute
care hospital to a long-term acute care or weaning centre ear-
lier than in our study.
Five factors were found to be independently associated with
hospital mortality in very long stay patients. The information
required to determine whether each of these factors is appli-
cable to a particular patient is readily available to clinicians.
Hospital survival decreased markedly as the number of non-
age-related hospital mortality predictors increased. However,
cautious extrapolation of these findings to other patients is
warranted, given the relatively small number of patients with
more than one non-age-related mortality predictor in the study
cohort.
It may be difficult to discuss changing the focus of care with
patients and their families after 30 days in ICU when extensive
resources have already been invested. However, given the
prognostic implications, if the introduction of new life support
therapies in this patient population becomes necessary
because of clinical deterioration, then the outcome information
derived from this study can help to further inform and guide the
decision-making process.
Although the effect of age is a statistically significant factor, its
effect is considerably smaller than that of the other factors. For
example, a patient 20 years older than the average age in our
cohort of 63 who survived to 30 days in ICU would still have
an expected hospital survival of about 40%, only somewhat
lower than the overall cohort average of 58% (i.e. an OR of
mortality of [1.45]2 for two decades). Furthermore, other than
Figure 4
Hospital survival by number of non-age-related clinical predictors identified by multivariate logistic regression analysis Hospital survival by number of non-age-related clinical predictors identified by multivariate logistic regression analysis. ICU, intensive care unit; se, 
standard error.
Figure 3
Hospital survival by number of ICU readmissions during the hospital stay Hospital survival by number of ICU readmissions during the hospital stay. ICU, intensive care unit; se, standard error.Available online http://ccforum.com/content/10/2/R59
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immunosuppression, no other co-morbidities were consist-
ently found to have a large impact on survival. A potential
explanation for this finding is that baseline co-morbidities are
important predictors of short-term survival, but patients surviv-
ing to 30 days have demonstrated sufficient physiological
reserve, despite their advanced age or any other co-morbidi-
ties. New physiological derangements, as reflected in ongoing
or new requirements for life support therapies, become the
important factors associated with survival.
A few studies, primarily in cardiac surgery or trauma patients
and in long-term ventilator weaning centres, have identified
similar predictors of poor outcome including age
[5,12,16,19,28-30], inotrope requirements or nosocomial
sepsis [5,16], immunosuppression [16], need for renal
replacement therapy [10,16], and multiple organ failures [31].
One study [17] did not find total days of mechanical ventilation
to be related to survival; however, that study only compared
patients ventilated for 29–46 days versus those ventilated 47
or more days, and did not further separate out patients venti-
lated for longer time periods.
The present study has a number of limitations. The data gen-
erated may not be generalizable because they are derived from
the experience of a single centre and reflect a unique organi-
zation and process of care. For example, the results may not
directly apply to hospital systems with intermediate care/step
down units for high intensity patients not requiring mechanical
ventilation, or for hospital systems with more readily available
chronic ventilator units. A factor that may affect outcomes is
the approach to treatment limitation, which is likely to differ at
least to some degree between centres. Although the practice
in our centre is not to continue life support therapies in cases
of futility, this is a complex issue influenced by patient and fam-
ily values and with some variability in opinion and practice
between individual clinicians. Furthermore, our hospital does
not perform solid organ transplant surgery (other than kidneys)
and the medical/surgical ICU does not routinely admit cardiac
surgery or neurosurgical/trauma patients, and so the results
may not be applicable to these patient groups. However, other
studies identifying predictors of outcome in cardiac surgery
[5], some including heart and lung transplantation [16], and
trauma patients [12] have identified similar prognostic factors.
This may suggest that once patients have overcome their initial
reason for ICU admission (complex surgery, trauma, sepsis
and so on.) and have survived to 30 days, they begin to face
similar issues associated with prolonged dependence on life
support (for example secondary infections and complications
secondary to prolonged immobility).
Although the number of patients enrolled in the present study
is relatively large, given the rarity of patients with very long ICU
stays, it is still a relatively small number from a statistical per-
spective, which limits the precision of the OR estimates for the
predictors and reduces the power to detect predictors with
lower ORs. Furthermore, it is difficult to correlate the severity
of the risk factor to outcome (for example the degree of immu-
nosuppression) or to determine whether subcategories are
important (such as lung cancer compared with other types of
cancer) [32]. A further loss of precision may have occurred by
changing continuous predictor variables into binary variables
(which were chosen to be more readily available to clinicians
at the bedside). Other factors, some of which are difficult to
measure objectively, that may influence patient outcomes
were not recorded in our data collection. These include the
use of neuromuscular blocking agents, which were infre-
quently used in our patients, presence of delirium and high
sedative use.
Finally, quality of life in survivors was not measured. Many pre-
vious studies have shown that quality of life in patients surviv-
ing long ICU stays is reasonably good [7,11,26,33-37].
Although quality of life was not measured in our study, most
survivors returned to their previous place of residence, which
is an important quality of life indicator for many critically ill
patients and their families.
Conclusion
In summary, the outcome predictors identified in this study are
readily available to treating physicians and suggest that pro-
longed requirements for various life support therapies (ventila-
tion, inotropes or vasopressors, and acute dialysis), in addition
to immunosuppression and (to a lesser extent) patient age, are
more important than other pre-existing co-morbidities for
Table 3
Results of multivariate logistic regression analysis of patient characteristics associated with hospital mortality
Clinical mortality predictor OR (95% CI) P
Age (per 10-year increase) 1.45 (1.10–1.91) 0.009
Immunocompromised 5.2 (1.7–15.5) 0.003
>90 Ventilator days 4.0 (1.3–12.0) 0.013
3 days of inotropes/vasopressors from day 30 in ICU 7.1 (2.6–19.3) 0.0001
ARF requiring dialysis from day 30 in ICU (excluding ESRD patients) 6.3 (2.0–19.7) 0.0015
ARF, acute renal failure; CI, confidence interval; ESRD, end-stage renal disease; ICU, intensive care unit; OR, odds ratio.Critical Care    Vol 10 No 2    Friedrich et al.
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determining hospital mortality in very long stay ICU patients.
Clinical decisions regarding individual very long stay patients
clearly require incorporating other individualized clinical infor-
mation in addition to patient values and beliefs. However, the
predictors identified in this study may assist this decision mak-
ing process, and their reproducibility in other very long stay
patient populations should be explored. The identification of
accurate predictors of hospital survival is important because
the decision to withdraw or limit life-sustaining therapy in ICU
patients is greatly influenced by physician's prediction of
patients' ability to survive their ICU stay [38,39]. It is particu-
larly important for this patient population because outcomes
are favourable in many cases, with around half of the patients
surviving and the vast majority of survivors returning to their
previous place of residence and remaining there for at least 6
months after hospital discharge.
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